Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

BACKGROUND: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine's effect on infectivity is thus a critical priority. METHODS: Among all 9650 HCW of a large tertiary...

Descripción completa

Detalles Bibliográficos
Autores principales: Regev-Yochay, Gili, Amit, Sharon, Bergwerk, Moriah, Lipsitch, Marc, Leshem, Eyal, Kahn, Rebecca, Lustig, Yaniv, Cohen, Carmit, Doolman, Ram, Ziv, Arnona, Novikov, Ilya, Rubin, Carmit, Gimpelevich, Irena, Huppert, Amit, Rahav, Galia, Afek, Arnon, Kreiss, Yitshak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261633/
https://www.ncbi.nlm.nih.gov/pubmed/34250518
http://dx.doi.org/10.1016/j.lanepe.2021.100150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261633/
https://www.ncbi.nlm.nih.gov/pubmed/34250518
http://dx.doi.org/10.1016/j.lanepe.2021.100150

Ejemplares similares